PATIENT SAFETY
streamlined equipment in theatre, integrating multiple third-party devices into a single display. This allows simultaneous viewing of a variety of parameters for rapid insight into the patient’s status. Cardiac output and a variety of other critical data can be displayed on the monitor screen, helping to inform clinical decisions, enhance clinical efficiency and ultimately improve patient outcomes. This helps the hospital to optimise patient management according to their cardiac stability.
The R&D team at Mindray was also able to turn around bespoke connectivity solutions to Royal Papworth at record speed. In less than a week, the company developed software to enable the monitor to collect all of the data from their anaesthetic machine, along with the ability to display the CO2
waveform. Mindray
has also been working closely with LivaNova, a manufacturer of cardiovascular and neuromodulation solutions, to provide the ability to connect the company’s bypass machine with the BeneLink module. “When indicated, it is valuable to have information, such as the flow of the bypass machines, so that everyone knows what the SVO2 is on bypass and the current flow,” comments Dr Falter. “Space is always at a premium, so being able to visualise all of this information via the one monitor will make it easier to keep an eye on what is going on in theatre. Having this flexibility will not only improve patient safety but make my life easier,” commented Dr Falter.
New site goes live
The first patients were admitted to the new hospital facility on 1 May 2019 and, after 101 years of saving lives and transforming medicine, the Papworth Everard site officially closed on 4th May. Four operations took place at the new site on the first day of activity (1 May) – two thoracic cases and two cardiac cases –
as well as eight procedures in the cath labs. During the move from the old site to the new hospital, a total of six clinical application specialists (CAS) from Mindray were on-site for two weeks, to support the transition – ensuring the process was as smooth as possible. “Providing this level of support is about going the extra mile and ensuring the clinical staff were put at ease at what was potentially a stressful time. They were not just having to deal with new monitors but change on a huge scale,” said Mindray’s clinical application specialist, Emily Best.
Looking to the future
Close collaboration with clinical partners at Royal Papworth will ensure the technology remains cutting-edge and evolves with the changing demands of the hospital for years to come. Responsible for driving the installation from a clinical engineering perspective, Royal Papworth’s electro- medical services manager, Paul Robbins, explained the importance of partnering with a supplier that can ensure their technology remains “state-of-the-art”. “Royal Papworth provides cutting-edge innovation in its field and we wanted to use technology that reflected this, with the ability to move and evolve as we move and evolve. Mindray’s solution offered the greatest scope to achieve this,” Robbins said. The hospital is currently using around 50% of the BeneView’s potential functionality, but there is scope to significantly expand on this, in the years to come, as the hospital scales-up utilisation of the system’s full capabilities to meet its evolving demands. Royal Papworth is now looking at the next possible steps in terms of functionality – from neuro observations, such as the Glasgow Coma Scale (a measure of consciousness and responsiveness in patients), to epidural
50 I
WWW.CLINICALSERVICESJOURNAL.COM
observations and PCO2
recording. There is
also interest in the potential for telemetry – this function will enable continuous monitoring while the patient remains active, without the restriction of being attached to a bedside cardiac monitor. “We are just at the start of our journey with Mindray,” Robbins concluded.
Key Outcomes
The hospital now has comprehensive patient monitoring, throughout the patient journey, reducing the gaps in data to ensure maximum patient visibility and safety.
The flow of patient data directly from the monitor and into the EPR improves safety and releases time to care, through more efficient workflows and the reduction of manual transcription.
Staff can now avoid patient misidentification at the point of care, with positive patient identification on- screen via ADT lookup.
Staff and management are now confident in the accuracy of the observations and NEWS2 calculations, ultimately helping save lives.
Enhanced patient safety through rapid identification of deterioration, the automated notification process is helping to speed up intervention by the outreach team.
Integrated 12-lead ECGs has created time efficiencies and eliminated the need for standalone ECG devices, maximising the investment and streamlining equipment inventory.
Streamlined equipment in theatre, integrating multiple third-party devices into a single display.
AUGUST 2019
CSJ
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92
